TITLE:
Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula

CONDITION:
Diabetic Macular Edema

INTERVENTION:
pegaptanib sodium (Macugen)

SUMMARY:

      The purpose of the study is to determine whether pegaptanib sodium (Macugen) is safe and
      effective in slowing the leakage of fluid within the retina and thereby stabilizing or
      improving vision when compared to placebo injections. A total of 176 patients will be
      enrolled
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

        Patients with clinically significant DME, VA 20/50-20/320 in the study eye and 20/100 in
        the fellow eye
      
